Pubmed

01-03-2021 Pubmed

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera [...]

Barbui T, Vannucchi AM, De Stefano V, et al. Lancet Haematol 2021, 8(3): e175-e184.
15-02-2021 Pubmed

Prevalence and risk factors for Pulmonary Hypertension associated with chronic [...]

Ferrari A, Scandura J, Masciulli A, Krichevsky S, Gavazzi A, Barbui T. Eur J Haematol 2021 Feb, 106(2): 250-259.
04-02-2021 Pubmed

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the [...]

Barbui T, De Stefano V, Alvarez-Larran A, et al. Blood Cancer J 2021, 11(2): 21.
03-02-2021 Pubmed

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after [...]

Barbui T, Vannucchi AM, Alvarez-Larran A, et al. Leukemia 2021, 35(2):485-493.
18-01-2021 Pubmed

Addressing Key Clinical Care and Clinical Research Needs in Severe [...]

Nacoti M, Fazzi F, Biroli F, et al. Front Pediatr 2021, 8: 594425.
11-12-2020 Pubmed

Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still [...]

Introna M, Golay J. Front Immunol. 2020, 11:609063.
28-10-2020 Pubmed

The Role of Complement in the Mechanism of Action of [...]

Golay J, Taylor RP. Antibodies (Basel) 2020, 9(4):58.
20-05-2020 Pubmed

Combined Anti-Cancer Strategies Based on Anti-Checkpoint Inhibitor Antibodies

Golay J, Andrea AE. Antibodies (Basel) 2020, 9(2):17.
04-03-2020 Pubmed

Utility of routine evaluation of sterility of cellular therapy products [...]

Golay J, Pedrini O, Capelli C, et al. Cytotherapy 2018, 20: 262-270.
01-03-2020 Pubmed

Second cancers in MPN: Survival analysis from an international study.

Marchetti M, Ghirardi A, Masciulli A, et al. Am J Hematol 2020, 95: 295-301.
25-02-2020 Pubmed

The new WHO classification for essential thrombocythemia calls for revision [...]

Barbui T, Thiele J, Ferrari A, Vannucchi AM, Tefferi A. Blood Cancer J 2020, 10: 22.
06-02-2020 Pubmed

Monoclonal Antibody Monitoring: Clinically Relevant Aspects, A Systematic Critical Review.

Regazzi M, Golay J, Molinaro M. Ther Drug Monit 2020, 42: 45-56.